Publication of Circular

RNS Number : 2054G

IXICO plc

18 November 2015

 



18 November 2015

IXICO plc

("IXICO" or the "Company")

Publication of Circular and Notice of General Meeting

18 November 2015: IXICO plc (AIM: IXI), the brain health company, today confirms that further to the announcement made earlier today, a Circular has been published and will be posted to shareholders today in relation to the Proposed Acquisition, Placing, Broker Option, Rule 9 Waiver and Share Restructuring (all of which remain subject to approval by shareholders at a General Meeting to be held on 7 December 2015).

A copy of the Circular will shortly be available on the Company's website at the following URL: http://www.ixico.com/investors/companydocuments.

For further information, please contact:

IXICO plc	Tel: [phone]
Derek Hill, CEO
Susan Lowther, CFO
Charles Spicer, VP Corporate Development
Peel Hunt LLP (Nominated Adviser and Broker)	Tel: [phone]
James Steel
Oliver Jackson
Sohail Akbar
FTI Consulting Limited (Investor Relations)	Tel: [phone]
Simon Conway
Mo Noonan
Matthew Moss

Notes to Editors

About IXICO

IXICO, the brain health company, uses its innovative and proprietary digital platform technologies to help those involved in researching and treating serious diseases to make rapid, informed decisions targeted at improving patient outcomes.  IXICO has significant experience working with global pharmaceutical and biotechnology companies supporting clinical studies in the field of neuro-degenerative disorders including dementia, Alzheimer's disease, Huntington's disease and Multiple Sclerosis. 

More information is available on www.ixico.com 

 

END

 

 

CIRPKFDNPBDDNDD